WPW
LLY icon

Waldron Private Wealth’s Eli Lilly LLY Stock Holding History

Waldron Private Wealth’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.89M Buy
8,243
+107
+1% +$109K 0.34% 41
2026
Q1 		$7.48M Buy
8,136
+186
+2% +$189K 0.29% 44
2025
Q4 		$8.54M Buy
7,950
+101
+1% +$96.6K 0.34% 44
2025
Q3 		$5.99M Buy
7,849
+114
+1% +$84.8K 0.24% 49
2025
Q2 		$6.03M Sell
7,735
-44
-0.6% -$34.2K 0.26% 49
2025
Q1 		$6.42M Sell
7,779
-6,334
-45% -$5.27M 0.3% 43
2024
Q4 		$10.9M Buy
14,113
+74
+0.5% +$61.3K 0.44% 41
2024
Q3 		$12.4M Sell
14,039
-28
-0.2% -$25.2K 0.52% 37
2024
Q2 		$12.7M Buy
14,067
+27
+0.2% +$21.6K 0.57% 35
2024
Q1 		$10.9M Buy
14,040
+208
+2% +$148K 0.49% 36
2023
Q4 		$8.06M Sell
13,832
-6
-0% -$3.5K 0.38% 40
2023
Q3 		$7.43M Buy
13,838
+95
+0.7% +$49K 0.39% 42
2023
Q2 		$6.45M Buy
13,743
+48
+0.4% +$20.1K 0.32% 44
2023
Q1 		$4.7M Buy
13,695
+2,059
+18% +$694K 0.23% 58
2022
Q4 		$3.76M Hold
11,636
– – 0.23% 68
2022
Q3 		$3.76M Buy
11,636
+1,813
+18% +$574K 0.23% 68
2022
Q2 		$3.18M Buy
9,823
+480
+5% +$144K 0.18% 79
2022
Q1 		$2.67M Buy
9,343
+242
+3% +$62.3K 0.14% 97
2021
Q4 		$2.51M Sell
9,101
-20
-0.2% -$5.07K 0.12% 102
2021
Q3 		$2.11M Buy
9,121
+3,349
+58% +$827K 0.12% 102
2021
Q2 		$1.32M Buy
5,772
+358
+7% +$71.9K 0.08% 119
2021
Q1 		$1.01M Buy
5,414
+130
+2% +$25.4K 0.07% 130
2020
Q4 		$892K Sell
5,284
-185
-3% -$27.6K 0.07% 137
2020
Q3 		$809K Buy
5,469
+358
+7% +$55.4K 0.07% 126
2020
Q2 		$839K Buy
5,111
+172
+3% +$26.4K 0.07% 117
2020
Q1 		$685K Buy
4,939
+345
+8% +$47.4K 0.07% 125
2019
Q4 		$603K Buy
4,594
+83
+2% +$9.62K 0.05% 147
2019
Q3 		$504K Sell
4,511
-1,016
-18% -$113K 0.05% 146
2019
Q2 		$612K Sell
5,527
-135
-2% -$15.9K 0.07% 121
2019
Q1 		$734K Buy
5,662
+394
+7% +$47.9K 0.08% 111
2018
Q4 		$609K Buy
5,268
+717
+16% +$80.1K 0.09% 108
2018
Q3 		$488K Buy
4,551
+58
+1% +$5.8K 0.1% 102
2018
Q2 		$383K Buy
4,493
+30
+0.7% +$2.46K 0.08% 109
2018
Q1 		$345K Hold
4,463
– – 0.08% 113
2017
Q4 		$376K Buy
4,463
+600
+16% +$51.1K 0.09% 98
2017
Q3 		$330K Hold
3,863
– – 0.09% 102
2017
Q2 		$317K Sell
3,863
-1,085
-22% -$88.5K 0.1% 88
2017
Q1 		$415K Buy
4,948
+1,574
+47% +$126K 0.1% 125
2016
Q4 		$248K Sell
3,374
-370
-10% -$27.6K 0.09% 113
2016
Q3 		$300K Buy
3,744
+100
+3% +$8K 0.11% 90
2016
Q2 		$286K Sell
3,644
-284
-7% -$21.4K 0.11% 108
2016
Q1 		$282K Sell
3,928
-347
-8% -$26.3K 0.11% 101
2015
Q4 		$360K Buy
4,275
+244
+6% +$20.2K 0.13% 90
2015
Q3 		$337K Buy
4,031
+369
+10% +$31.2K 0.15% 71
2015
Q2 		$305K Buy
3,662
+522
+17% +$39.8K 0.12% 71
2015
Q1 		$228K Buy
3,140
+108
+4% +$7.69K 0.09% 109
2014
Q4 		$209K Buy
+3,032
New +$205K 0.09% 117

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Waldron Private Wealth's LLY Position: Q2 2026 in Review

Waldron Private Wealth increased its Eli Lilly (LLY) stake by 1.3% in Q2 2026, buying an estimated $109K and bringing the position to 8,243 shares worth $9.89M. The position accounts for 0.34% of the portfolio, ranked #41.

Waldron Private Wealth first reported a position in LLY in Q4 2014 and has held it in 47 quarters since. The position peaked at $12.7M in Q2 2024. 1,613 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Waldron Private Wealth held 8,243 shares of Eli Lilly worth $9.89M as of Q2 2026.
  • Waldron Private Wealth bought 107 Eli Lilly shares in Q2 2026, an estimated $109K.
  • Eli Lilly made up 0.34% of Waldron Private Wealth's portfolio in Q2 2026, its #41 holding.
  • Waldron Private Wealth first reported a position in Eli Lilly in Q4 2014 and has held it in 47 quarters since.
  • Waldron Private Wealth's Eli Lilly position peaked at $12.7M in Q2 2024.
  • 1,613 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Waldron Private Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.